Study how stress affects lung cancer treatment outcomes
Part of Cancer, Lungs & breathing clinical trials.
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old
- You have confirmed lung cancer (non-small cell or small cell, depending on the group)
- Your cancer stage must fit one of the study groups (early stage or advanced/metastatic/recurrent)
- You must not have had prior “systemic” cancer treatment (like chemo, targeted therapy, or immunotherapy)
- Your health status should be good enough (ECOG 0–1)
- You can complete required psychology/stress questionnaires (and you’re not on anti-anxiety or anti-depressant medicines)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This study looks at a supportive website designed to help people with lung cancer who feel anxious or stressed while waiting for scan results or news. Participating may help you manage worry and feel more in control during this difficult time.
This study looks at how emotional stress affects how well immunotherapy works for liver cancer. It is for people with liver cancer who are about to start immunotherapy, either before or after surgery, or as first treatment for advanced cancer.
This study monitors how the heart and lungs respond to radiation therapy combined with immunotherapy for locally advanced lung cancer. It aims to learn how well patients tolerate treatment and to detect early signs of side effects.
This study looks at whether chronic stress changes how well immunotherapy (ICI therapy) works in people with esophageal cancer. It may help doctors understand who benefits most from treatment and how stress could affect outcomes.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.